• Thumbnail for Glioblastoma
    Glioblastoma, previously known as glioblastoma multiforme (GBM), is the most aggressive and most common type of cancer that originates in the brain, and...
    78 KB (8,704 words) - 00:23, 13 November 2024
  • The Glioblastoma Foundation (GF) is a United States non-profit charitable organization established in June 2016 in Durham, North Carolina. Operating as...
    6 KB (554 words) - 06:14, 11 November 2024
  • Thumbnail for Brain tumor
    in adults are meningiomas (usually benign) and astrocytomas such as glioblastomas. In children, the most common type is a malignant medulloblastoma. Diagnosis...
    86 KB (9,309 words) - 04:48, 14 November 2024
  • States and Europe for the treatment of newly diagnosed and recurrent glioblastoma, malignant pleural mesothelioma (MPM), and is undergoing clinical trials...
    24 KB (2,465 words) - 10:27, 20 September 2024
  • Thumbnail for Glioma
    progression to sporadic glioblastoma. For instance, methylation of the DNA repair gene MGMT promoter was observed in 51% to 66% of glioblastoma specimens. In addition...
    64 KB (6,986 words) - 10:49, 9 October 2024
  • Thumbnail for Giant-cell glioblastoma
    The giant-cell glioblastoma is a histological variant of glioblastoma, presenting a prevalence of bizarre, multinucleated (more than 20 nuclei) giant (up...
    9 KB (870 words) - 10:53, 20 January 2024
  • Thumbnail for Temozolomide
    others, is an anticancer medication used to treat brain tumors such as glioblastoma and anaplastic astrocytoma. It is taken by mouth or via intravenous infusion...
    33 KB (2,959 words) - 02:09, 16 July 2024
  • Thumbnail for Blastoma
    neuroblastoma, pancreatoblastoma, pleuropulmonary blastoma, retinoblastoma, glioblastoma multiforme and gonadoblastoma. Hepatoblastoma (HBL) is the first and...
    13 KB (1,699 words) - 18:30, 25 February 2024
  • targets a mutant protein called EGFRvIII present in about 25% to 30% of glioblastoma cases. The vaccine consists of the EGFRv3-specific peptide (a 13-amino...
    3 KB (246 words) - 23:17, 24 April 2024
  • Thumbnail for Plus Therapeutics
    Obisbemeda is a Rhenium-186 radiolabeled therapeutic targeting recurrent glioblastoma, leptomeningeal metastases, and pediatric brain cancers. Their BMEDA...
    17 KB (2,003 words) - 18:32, 17 June 2024